Excitement over use of Ebola vaccine in outbreak tempered by real-world challenges

Successful use of the vaccine requires response planners and vaccination teams to hit the right notes on several challenging communications messages, said the CEO of Gavi, the Vaccine Alliance, a public-private partnership that assists developing countries with immunization programs.

‘You’re holding your breath’: Scientists who toiled for years on an Ebola vaccine see the first one put to the test

A standard randomized clinical trial doesn’t work when a pathogen circulates as rarely as Ebola does - researchers could vaccinate thousands of people and follow them for years without seeing any disease in the vaccine recipients or the control group.